Addition of levosimendan to overcome acute cardiogenic shock—Paving the way for later heart transplantation—A first case report
Christian Flottmann, Daniel Dumitrescu, Christian Sohns and 2 more
Clinical Case Reports · 2021
doi:10.1002/ccr3.3672 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
Abstract Treatment of refractory cardiogenic shock has poor outcome. Levosimendan addition may help to achieve hemodynamic stabilization and improve conditions to where further treatment options such as listing for heart transplantation may become possible.
Abstract licence: CC BY-NC
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.